Tissue-engineered bone used in a rabbit model of lumbar intertransverse process fusion: A comparison of osteogenic capacity between two different stem cells.
Wang H, Zhou Y, Li CQ, Chu TW, Wang J, Huang B.
Exp Ther Med. 2020 Apr;19(4):2570-2578. doi: 10.3892/etm.2020.8523. Epub 2020 Feb 11.
Changes in bone mineral density in the intertransverse fusion mass after instrumented single-level lumbar fusion: a prospective 1-year follow-up.
Hagenmaier F, Kok D, Hol A, Rijnders T, Oner FC, van Susante JL.
Spine (Phila Pa 1976). 2013 Apr 15;38(8):696-702. doi: 10.1097/BRS.0b013e318276fa27.
Bone mineral densities of the vertebral body and intertransverse fusion mass after instrumented intertransverse process fusion.
Lee JS, Kim KW.
Spine (Phila Pa 1976). 2010 Oct 1;35(21):E1106-10. doi: 10.1097/BRS.0b013e3181e1a275.
Dorsal root ganglion electrical stimulation promoted intertransverse process spinal fusion without decortications and bone grafting: a proof-of-concept study.
Lau YC, Lai YM, Po KT, Qian X, Hao HW, Zhao HC, Li LM, Guo X.
Spine J. 2014 Oct 1;14(10):2472-8. doi: 10.1016/j.spinee.2014.04.001. Epub 2014 Apr 13.
Low-intensity pulsed ultrasound enhances healing of laminectomy chip bone grafts on spinal fusion: a model of posterolateral intertransverse fusion in rabbits.
Liao JC, Chen WJ, Chen LH, Lai PL, Keorochana G.
J Trauma. 2011 Apr;70(4):863-9. doi: 10.1097/TA.0b013e3181e7c13d.
Intertransverse lumbar interbody fusion.
Phillips FM, Cunningham B.
Spine (Phila Pa 1976). 2002 Jan 15;27(2):E37-41. doi: 10.1097/00007632-200201150-00019.
Early-term and mid-term histologic events during single-level posterolateral intertransverse process fusion with rhBMP-2/collagen carrier and a ceramic bulking agent in a nonhuman primate model: implications for bone graft preparation.
Khan SN, Toth JM, Gupta K, Glassman SD, Gupta MC.
J Spinal Disord Tech. 2014 Jun;27(4):212-9. doi: 10.1097/BSD.0b013e3182767c67.
Evaluation of HealosMP52 osteoinductive bone graft for instrumented lumbar intertransverse process fusion in sheep.
Kim DH, Jahng TA, Fu TS, Zhang HY, Novak SA.
Spine (Phila Pa 1976). 2004 Dec 15;29(24):2800-8. doi: 10.1097/01.brs.0000148155.79353.ac.
Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion.
Martin GJ Jr, Boden SD, Titus L.
Spine (Phila Pa 1976). 1999 Nov 1;24(21):2188-93; discussion 2193-4. doi: 10.1097/00007632-199911010-00003.
Nitric oxide modulates recombinant human bone morphogenetic protein-2-induced corticocancellous autograft incorporation: a study in rat intertransverse fusion.
Diwan AD, Khan SN, Cammisa FP Jr, Sandhu HS, Lane JM.
Eur Spine J. 2010 Jun;19(6):931-9. doi: 10.1007/s00586-009-1263-7. Epub 2010 Jan 9.
